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International genome-wide meta-analysis identifies
new primary biliary cirrhosis risk loci and targetable
pathogenic pathways
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Primary biliary cirrhosis (PBC) is a classical autoimmune liver disease for which effective
immunomodulatory therapy is lacking. Here we perform meta-analyses of discovery data sets
from genome-wide association studies of European subjects (n¼ 2,764 cases and 10,475
controls) followed by validation genotyping in an independent cohort (n¼ 3,716 cases and
4,261 controls). We discover and validate six previously unknown risk loci for PBC
(Pcombinedo5 10 8) and used pathway analysis to identify JAK-STAT/IL12/IL27 signalling
and cytokine–cytokine pathways, for which relevant therapies exist.
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P
rimary biliary cirrhosis (PBC) is a rare cholestatic liver
disease characterized by progressive autoimmune
destruction of intrahepatic bile ducts, leading to cirrhosis
and liver failure in a substantial proportion of cases1. To date,
four genome-wide association studies (GWAS) and two Illumina
immunochip studies of PBC have confirmed associations at
the human leukocyte antigen (HLA) locus and identified 27
non-HLA risk loci2–8. Consistent with GWAS data for other
autoimmune diseases, results of these studies implicate
immune-related genes in disease pathogenesis, but in general
fail to pinpoint the disease-causal variants within the identified
risk loci. To identify risk alleles that may be relevant to disease
biology and treatment and illuminate additional PBC risk loci, we
undertook a genome-wide meta-analysis (GWMA) combining
North American, Italian and UK PBC GWAS data sets2,4,5.
Functional annotation of the risk loci and pathway analyses were
then performed to identify the alleles and pathways most relevant
to disease cause and treatment.
Results
Discovery of new PBC risk loci. Following quality control, the
combined discovery data set for GWMA consisted of 1,143,634
genotyped or imputed single-nucleotide polymorphisms (SNPs)
in 2,764 cases and 10,475 controls (Supplementary Table 1). After
genomic control correction and exclusion of known PBC risk loci
from the final set of results, the inflation factor was l¼ 1.043
(Supplementary Fig. 1). Meta-analysis of this data set identified
23 loci at genome-wide level of significance (Po5 10 8,
calculated using logistic regression of individual discovery data
sets in ProbABEL followed by genomic control correction of
individual discovery data sets in R and fixed-effects meta-analysis
in META, see Methods). Of these, 22 had been detected in
previous studies and the 23rd corresponded to a most-likely
spurious signal from a single imputed SNP on chromosome 13
(Supplementary Fig. 2, Supplementary Table 2). However, we
found suggestive evidence of association (Po2 10 5 from
fixed-effects meta-analysis in META) at 41 loci not previously
known to be associated with PBC. The top-scoring SNPs (or close
proxies in strong linkage disequilibrium with the top-scoring
SNP) from these and nine other loci (including the likely spurious
chromosome 13 signal) were taken forward for genotyping in an
independent panel consisting of 3,716 PBC cases and 4,261
controls. In total, 120 SNPs at 50 independent loci were taken
forward for validation, of which 114 were successfully genotyped
(Supplementary Data 1).
In the validation analysis, we confirmed association with SNPs
at six loci not previously known to be associated with PBC
(Po4.4 10 4, equivalent to P¼ 0.05 with a Bonferroni
correction for 114 tests, calculated using logistic regression
analysis of individual validation data sets in PLINK followed by
meta-analysis in META, see Methods); meta-analysis of discovery
and validation cohorts at these loci reached genome-wide levels
of significance (Pcombined o5 10 8 from fixed-effect meta-
analysis in META) (Table 1, Supplementary Figs 3 and 4).
Furthermore, SNPs at two additional loci achieved P values
suggestive of association (Po1 10 3 from fixed-effect meta-
analysis in META, equivalent to P¼ 0.05 with a Bonferroni
correction for testing at 50 independent loci; Table 1,
Supplementary Fig. 5). Newly identified PBC risk loci overlap
with those of other autoimmune disorders and harbour several
immunologically relevant candidate genes, most notably chemo-
kine ligand 20 (CCL20) and interleukin 12B (IL12B; Table 1).
Discovery of candidate causal disease variants. In functional
annotation of risk loci, we identified 199 candidate variants across
28 non-HLA risk loci with probabilistic identification of causal
SNPs (PICS) probability 40.0275 (ref. 9). At each risk locus, the
most-likely causal variant was the index variant, with median
PICS probability of 0.224 and values up to 0.998 for rs2546890 at
5q33.3 (Supplementary Data 2). Looking at all candidate variants
across all risk loci, the majority were intronic, upstream or
downstream gene variants with no predicted functional con-
sequence (99/199, 40%). However, a substantial proportion
(59/199, 30%) were regulatory region variants, defined as SNPs
located within regulatory features, including enhancers, pro-
moters, transcription factor-binding sites and open chromatin
regions (Supplementary Data 3). Notably, candidate variants at
18 (64%) of the 28 annotated risk loci included at least one
regulatory region variant. In contrast, only 5 of 199 candidates
were missense variants (2.5%) (Supplementary Table 3a).
However, these included rs2297067 in EXOC3L4 at 14q32.32 and
rs2304256 in TYK2 at 19p13.2, both predicted by SIFT and/or
PolyPhen to be deleterious or potentially damaging10,11.
Candidate variants included a single splice region variant, that
is, rs17641524 at 1q31.3 that is predicted to affect splicing of
DENND1B (Supplementary Table 3b).
We found that candidate variants at several risk loci are
methylation quantitative trait loci (mQTLs), including mQTLs
for DENNDIB, PLCL2, IRF5 and TNFRSF1A, all genes that are
implicated in risk for other autoimmune diseases (Supplementary
Data 4). We also found that candidate variants at several risk loci
are expression quantitative trait loci (eQTLs) in lymphoblastoid
and other cell lineages, including eQTLs for CCL20, IL12A, IRF5
and TYK2 (Supplementary Data 5).
At many risk loci, functional annotation highlighted a single
candidate gene (Supplementary Data 2). However, most risk
loci contained multiple compelling candidate variants. This
complexity is well illustrated by the composite of candidate
variants at the PLCL2 gene and MANBA gene loci, which include
multiple eQTL and mQTL SNPs. Thus, despite the presence of
many candidate variants with regulatory or epigenetic roles
within PBC risk loci, more direct biological experimental
approaches are required to pinpoint the disease-causal variants
at these loci.
We also applied functional GWAS (FGWAS) and its associated
annotation file12 to our full set of discovery GWMA results
and thereby identified 75 annotations with enrichment (Po0.01
from FGWAS) of GWMA association signals (Supplementary
Data 6). After a stepwise selection approach similar to that of
Pickrell12, the best-fitting model included six annotations
highlighting negative enrichment of repressed chromatin
regions in a lymphoblastoid cell line, and positive enrichment
of DNase-I-hypersensitive sites in a variety of cell types, in
particular CD20þ and Th1 T cells (Supplementary Table 4).
Identification of candidate targetable biological pathways.
To identify biological pathways involved in development of
PBC, we conducted pathway analysis using GCTA13 followed by
i-GSEA4GWAS14. We identified several immunoregulatory
pathways associated with PBC, in particular, IL-12 and other
cytokines as well as T-cell signalling pathways. To account for
bias that might result from the strong HLA association with PBC,
we repeated this analysis with SNPs/genes in the HLA region
excluded. Notably, IL-12, IL-27 and JAK-STAT signalling
pathways were still associated with PBC, even after their HLA
contribution had been removed (Table 2).
We identified molecules that targeted these pathways by
overlaying the Drug Gene Interaction database15 and calculating
a pathway specificity score and Jaccard index of each drug for
each of the pathways that remained associated with PBC after the
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HLA contribution had been removed (Table 2, Supplementary
Data 7). This combined analysis identified pathways and
immunomodulatory agents that represent promising leads for
further study in models of PBC.
Discussion
The current study adds to our knowledge of the genetic
architecture of PBC. Notably, our data identify CCL20 as a
candidate risk gene for PBC. Chemokine ligand 20 (CCL20) and
its chemokine receptor CCR6 contribute to the formation and
function of mucosal lymphoid tissues and are notably, in the
context of the immune-mediated lymphocytic cholangitis char-
acteristic of PBC, involved in the localization of Th17 cells and
CD8 effector T cells to cholangiocytes and the periductal area in
portal tracts16. This study also reinforces the importance of IL-12
and JAK-STAT signalling in this disease.
The functional annotation of risk loci has helped to assign
priority to the candidate genes at newly identified and established
risk loci. Furthermore, the identification of disease-associated
regulatory variants at multiple risk loci emphasizes the potential
importance of gene regulation in the pathogenesis of PBC
(and presumably other complex disorders). This possibility is
corroborated by the finding of numerous risk loci wherein the
index and/or closely related SNPs that appear to represent
regulatory, mQTL and/or eQTLs variants related to the nearby
gene. Via the FGWAS analysis, this study also suggests particular
importance of CD20þ B cells and Th1 cells in the pathogenesis
of PBC. However, both the cell types and the specific gene
variants most relevant to PBC require further investigation and in
particular exploration of the tissue-specific functional effects of
the disease-associated variants.
By looking for drug–gene interactions, we have identified
candidate drugs targeting specific, PBC-associated pathways,
creating new opportunities to re-purpose available drugs for
targeted immune therapy. Despite the speculative nature of this
analysis, the data provide a start point in the search for novel
therapies that are urgently needed to improve outcomes for PBC
patients.
Methods
Study samples and genotyping. The use of human subjects for this study was
approved by the University Health Network Research Ethics Board, The Mayo
Clinic Institutional Review Board, Etico Indipendente IRCCS Istituto Clinico
Humanitas, UC Davis Institutional Review Board and the Oxford Research Ethics
Committee.
All PBC cases included in the Canadian–US, Italian and UK discovery and
validation cohorts fulfilled the American Association for the Study of Liver
Diseases criteria for PBC.
The Canadian–US discovery cohort included 499 PBC cases who were
self-reported whites of European descent and 390 healthy Canadian controls,
all genotyped using the Illumina HumanHap370 BeadChip. Additional controls
included in this cohort were 1,094 control subjects provided from the Prostate
Cancer Genetics Markers Susceptibility (CGEMS), 1,142 controls from the Breast
CGEMS studies and 1,748 controls from the New York Cancer Project, all of whom
who were genotyped on an Illumina 550 K bead array4. Following all quality
control (QC) procedures, the final Canadian–US discovery set included 499 PBC
cases and 4,374 controls.
The PBC cases included in the Italian discovery cohort were self-reported
whites of Italian descent genotyped using the Illumina Human610-Quad BeadChip.
Controls in this cohort were healthy Italians genotyped using the Illumina 1M-duo
Table 1 | PBC risk loci identified in the current study.
a. Confirmed risk loci (validation Po4.4 104 resulting in combined Po5 108)
Locus SNP Position
(build 38)
A1/A2 Discovery
P
Validation
P
Joint
P
OR (95% CI) Region (build 38) Nearby genes and
functional annotation*
Autoimmune
overlap
2q12.1 rs12712133 102,249,813 A/G 1.62 10 5 7.94 10 5 5.19 10 9 1.14 (1.07–1.21) 102,118,975–102,438,307 IL1R1, IL1RL2w,
FAM183DP, IL1RL1z,
IL18R1, LOC100422339,
IL18RAP, MIR4772
CD, CeD
2q36.3 rs4973341 227,795,646 C/T 6.48 10 7 7.73 10 5 2.34 10 10 0.82 (0.74–0.90) 227,747,828–227,815,647 RNA5SP121, SNRPGP8,
LOC100533842,
CCL20w,y
4p16.3 rs11724804 971,991 A/G 3.67 10 7 4.25 10 6 9.01 10 12 1.22 (1.12–1.33) 853,681–1,014,424 GAK, TMEM175,
DGKQw, SLC26A1a,
IDUA, FGFRL1
5q21.1 rs526231 103,345,680 T/C 3.10 10 5 9.39 10 5 1.14 10 8 0.87 (0.81–0.93) 102,939,698–103,416,571 PAMy, EIF3KP1, GIN1,
PPIP5K2, C5orf30z,y
RA
5q33.3 rs2546890 159,332,892 G/A 1.20 106 1.89 10 5 1.06 10 10 0.87 (0.82–0.93) 159,117,927–159,414,310 RNF145, UBLCP1,
RNU4ATAC2P, IL12B,
LOC285626w
Pso, MS, CD
6q23.3 rs6933404 137,638,098 C/T 9.47 10 7 2.84 10 5 1.27 10 10 1.18 (1.09–1.27) 137,571,557–137,803,754 LOC102723649,
LOC442263, OLIG3w,
TNFAIP3w
RA, SLE, SjS,
CeD, UC, MS
b. Suggestive risk loci (validation Po1 103)
Locus SNP Position
(build 38)
A1/A2 Discovery
P
Validation
P
Joint
P
OR for A1
(95% CI)
Region (build 38) Nearby genes and
functional annotation*
Autoimmune
overlap
5q23.1 rs2434360 116,057,393 T/G 3.20 10 3 9.94 104 1.04 10 5 1.14 (1.05–1.23) 116,032,882–116,163,459 RPS25P6, ARL14EPL,
COMMD10
16p11 rs1859308 27,386,677 T/C 7.72 10 5 5.37 104 1.63 10 7 0.85 (0.77–0.93) 27,359,133–27,434,733 IL4R, IL21R
A1, tested allele; CD, Crohn disease; CeD, coeliac disease; CI, confidence interval; MS, multiple sclerosis; OR, odds ratio in validation cohorts; Pso, psoriasis; RA, rheumatoid arthritis; SjS, Sjogren
syndrome; SLE, systemic lupus erythematosus; SNP, single-nucleotide polymorphism; UC, ulcerative colitis.
PBC risk loci identified in the current study. SNPs were taken forward for validation based on having a discovery P value o2 10 5 (or, in the case of rs526231 and rs2434360, based on acting as a
proxy for a SNP with a P valueo2 10 5). Discovery P values were calculated using logistic regression of individual discovery data sets in ProbABEL followed by genomic control correction of individual
discovery data sets in R and fixed-effects meta-analysis in META; validation P values were calculated using logistic regression of individual data sets in PLINK followed by fixed-effect meta-analysis in
META; joint P values were calculated using fixed-effect meta-analysis of discovery and validation data sets in META; see Methods. Autoimmune overlap refers to overlap between risk loci for PBC and
those of other autoimmune conditions.
*Functional annotation.
wRegulatory variants: The index SNP or variants in strong linkage disequilibrium (LD, r2Z0.8) with the index SNP at this locus overlap regulatory elements that are related to the annotated gene
(Supplementary Table 3).
zmQTLs: The index SNP or variants in strong LD are correlated to methylation related to the annotated gene (Supplementary Data 4).
yeQTLs: The index SNP or variants in strong LD are correlated to expression of the annotated gene (see Supplementary Data 3).
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array. Following QC procedures, the final Italian discovery set comprised 449 cases
and 940 controls.
The PBC cases included in the UK discovery cohort were self-reported whites
of British descent, genotyped using the Illumina Human-660W Quad array.
Controls in this cohort were 5,163 population controls genotyped on the Illumina
1M-Duo array as part of the Wellcome Trust Case Control Consortium 2 project.
Following QC procedures, the UK discovery set comprised 1,816 cases and 5,161
controls.
The ‘Canadian’ 903 PBC cases and 834 controls included in the validation
studies were self-reported whites of European descent recruited from Canada,
Europe and the United States to an ongoing PBC genetics study based in Toronto.
The 721 ‘US’ PBC cases and 294 controls included in the validation studies were
self-reported whites of European descent enroled in the Mayo Clinic PBC Genetic
Epidemiology registry and biorepository based at the Mayo Clinic in Rochester
(https://clinicaltrials.gov/ct2/show/NCT01161953?term=pbc&rank=5).The Italian
PBC cases and controls included in the validation studies were self-reported whites
of Italian descent recruited to the Italian PBC Genetics study based at Instituto
Humanitas in Milan. The Italian controls were obtained from Ospedale Alessandro
Manzoni, Lecco, Italy and were unrelated healthy volunteers with no known
non-Italian heritage. Cases and controls from the Canadian, Italian and the US
cohorts were genotyped at the University Health Network/Mount Sinai Hospital
Clinical Genomics Centre using a Sequenom iPLEX Gold assay. Following QC
procedures, the final validation set included 903 cases and 834 controls from
Canada; 300 cases and 618 controls from Italy; and 721 cases and 294 controls
from the United States (Supplementary Table 1).
The ‘UK’ PBC cases included in the validation studies were self-reported whites
of British descent recruited to the UK-PBC project via the UK-PBC Consortium
(http://www.uk-pbc.com/). Cases were genotyped using Sequenom iPLEX Gold
assay at the Wellcome Trust Sanger Institute Genotyping Facility (http://
www.sanger.ac.uk/). The UK validation control data were obtained from the
TwinsUK resource, an adult twin registry comprising 12,000 (predominantly
female) British twins. Genotype data for 3,512 twin individuals (genotyped using
the Illumina HumanHap610 array) were obtained from the Department of Twin
Research and Genetic Epidemiology at King’s College London. One twin from each
genotyped pair was included in the current study, amounting to 2,603 unrelated
individuals. Following QC procedures, the final UK validation set comprised 1,792
PBC cases and 2,515 TwinsUK controls (Supplementary Table 1).
Quality control. We implemented a standard QC pipeline across all three dis-
covery data sets, over-and-above QC procedures carried out in the respective
primary analyses2,4,5. QC checks were carried out using the software package
PLINK17. Within each discovery data set we removed SNPs with a genotype call
rate o95%; minor allele frequency o0.05; significant deviation from Hardy
Weinberg Equilibrium in controls (Po10 5) or a large difference (45%) in the
proportion of missing genotypes in cases versus controls. We removed samples
showing high rates of missing data (490%); whole-genome heterozygosity 4six
s.d. from the mean; estimated proportion of identity by descent (IBD) sharing with
another sample40.1, or apparent gender discrepancies (based on X-chromosomal
heterozygosity40.2 for men ando0.2 for women). Principal component analysis
(based on a subset of 32,000 highly informative SNPs) was carried out using the
‘smartpca’ routine of the EIGENSOFT package18 to identify population outliers for
exclusion and to identify principal components that differed between cases and
controls; these principal components were used as covariates in subsequent
association analyses.
Genome-wide imputation. We used the SNPs and samples passing QC to carry
out genome-wide imputation within each of our cohorts using the software
package MaCH19 with HapMap3 CEUþTSI samples as reference data sets. Within
each cohort we used approximately the same set of genotyped SNPs in cases and
controls to ensure similar levels of informativity. Following imputation, we retained
only those SNPs displaying minor allele frequency 40.005 and imputation quality
score R240.5 in all three cohorts.
Statistical analysis of discovery cohorts. Within each cohort we carried out
association analysis of the genome-wide imputed data allowing for imputation
uncertainty using the software package ProbABEL20. We performed logistic
regression of disease phenotype on allele dosage; principal components that
differed between cases and controls were included as covariates to help correct for
population stratification. Quantile–quantile plots of the genome-wide set of test
statistics were examined and genomic control correction was carried out within
each cohort by multiplying the standard error of the estimated log odds ratio for
each SNP by the square root of the genomic control inflation factor l (ref. 21). The
resulting log odds ratios and adjusted standard errors from all three cohorts were
Table 2 | Results from pathway analysis in iGSEA4GWAS.
Gene set Source FDR (with HLA) FDR (without HLA)
NO2-dependent IL-12 pathway in NK cells Biocarta 6.7 104
JAK-STAT signalling pathway*,w KEGG 0.001 0.013
IL-12 mediated signalling events PID 0.001
IL-12- and Stat4-dependent signalling in Th1 development*,w Biocarta o0.001
Interferon signalling REACTOME 0.001
PD-1 signalling REACTOME 0.001
Phosphorylation of CD3 and TCR-z chains REACTOME 0.001
IL-27-mediated signalling events*,w PID 0.001 o0.001
Cytokine–cytokine receptor interactionz,y,||,z,#,**,w,ww,zz KEGG 0.002 0.010
IFN-g signalling REACTOME 0.002
MHC class II antigen presentation REACTOME 0.003
Cytokine signalling in immune system REACTOME 0.004
Antigen processing and presentation KEGG 0.004
Intestinal immune network for IgA production KEGG 0.004
Co-stimulation by the CD28 family REACTOME 0.005
IL-2 mediated signalling events PID 0.008
TCR signalling REACTOME 0.008
Downstream TCR signalling REACTOME 0.008
Cell adhesion molecules KEGG 0.015
Th1, Th2 differentiationw Biocarta 0.019 0.012
IL-2 receptor beta chain in T-cell activation Biocarta 0.021
Interferon a/b signalling REACTOME 0.035
IL-23-mediated signalling events PID 0.039
FDR, false discovery rate; IFN, interferon; IL, interleukin; PD, programmed cell death; TCR, T cell antigen receptor; NK, natural killer.
Gene sets with FDR o0.05 are listed. Results are shown with or without inclusion in the analysis of SNPs within the HLA region. The top 10 hits from our drug-positioning analysis using a combined
pathway from the HLA excluded set are indicated by symbols for the associated pathways that they affect.
*Tofacitinib.
wGlatiramer acetate.
zAxitinib.
yPazopanib.
||Vatalanib.
zCediranib.
#X-82.
**Telatinib.
wwLinifanib.
zzTandutinib.
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meta-analysed using the software package META to produce the final set of
genome-wide discovery results22.
Validation analysis. We selected loci for validation if they achieved suggestive
level of significance in the discovery analysis (minimum Po2 10 5) and were
not already known to be associated with PBC. We also selected loci for validation if
they had achieved genome-wide significant association in one previous study but
had never been validated in an independent cohort. We selected approximately two
validation SNPs per locus; for loci displaying extended patterns of linkage dis-
equilibrium or harbouring several putative independent association signals we
attempted to select two validation SNPs within each subregion.
Within each locus chosen for validation we assigned priority to SNPs according
to whether they had been genotyped in the TwinsUK cohort (which was used as a
validation cohort for the UK validation cases). One SNP selected for validation
(rs2297067) did not have genotype data available in TwinsUK and was therefore
imputed within TwinsUK based on genotyped SNPs in the surrounding 5-Mb
region using the software packages SHAPEIT23 and IMPUTE2 (ref. 24), with 1,000
Genomes (Phase I version 3 integrated data, released on March 2012) used as a
reference sample. The TwinsUK cohort was subjected to a variety of additional QC
checks as described previously25; the 2,515 controls used here correspond to the
2,520 controls used previously with an additional five exclusions due to discrepant
gender25.
Within each validation cohort we carried out case/control association analysis
of those SNPs that were successfully genotyped using logistic regression in PLINK.
Results from the four validation cohorts (or from the combined discovery and
validation cohorts) were combined via meta-analysis in META.
Imputation to 1,000 Genomes within validated loci. Imputation within the
discovery cohorts was carried out at the six validated loci using the software
packages SHAPEIT23 and IMPUTE2 (ref. 24) with the 1,000 Genomes (Phase I
integrated variant set, release December and June 2013) used as a reference panel.
The same genotyped SNPs that had been used to inform HapMap3 imputation for
the discovery analysis were used for the 1,000 Genomes imputation within these
targeted regions. Association analysis of SNPs passing post-imputation QC (‘info’
score 40.5) was carried out separately within each cohort, the results were
genomic control corrected by multiplying the standard error of the estimated log
odds ratio for each SNP by the square root of the previously estimated genomic
control inflation factor l for each cohort, and results were combined across the
cohorts via meta-analysis in META. This confirmed the findings from our original
(HapMap3) imputation experiment but did not identify any substantially stronger
associations or candidate causal variants than we had already found.
Functional annotation of validated loci. Left and right boundaries for each
associated region were defined by finding a 0.1-cM interval either side of the most
strongly associated SNP where no SNP has Po1 10 5. We looked for overlap
between PBC risk loci and confirmed risk loci for other autoimmune conditions
using ImmunoBase, a web-based resource focused on the genetics and genomics of
immunologically related human diseases (http://www.immunobase.org/). To assign
priority to candidate genes and candidate variants at risk loci, we used the online
PICS (Probabilistic Identification of Causal SNPs) algorithm to identify candidate
variants at each risk locus with a PICS probability 40.0275 (http://www.broa-
dinstitute.org/pubs/finemapping/?q=pics)9. We adopted this threshold to be
consistent with Farh et al.9 in their paper describing the approach. Given an index
SNP corresponding to the most associated SNP in a locus, the PICS algorithm
calculates (based on the known linkage disequilibrium pattern in the region, as
measured in a large Immunochip or 1000 Genomes reference sample) a score for
each SNP in the region, representing the extent to which that SNP could, in fact, be
the true causal SNP, allowing for statistical sampling variation.
We then used the Ensembl Variant Effect Predictor web tool to annotate
candidate variants for their predicted functional consequences (http://
www.ensembl.org/info/docs/tools/vep/index.html). We used Genevar to evaluate
the measured effects of these variants on DNA methylation in tissue collected from
856 healthy female twins of the MuTHER resource (http://www.sanger.ac.uk/
resources/software/genevar/)26,27. We used Genevar26, seeQTL (http://
www.bios.unc.edu/research/genomic_software/seeQTL/)28 and the University of
Chicago eQTL browser (http://eqtl.uchicago.edu/cgi-bin/gbrowse/eqtl/) to identify
eQTLs amongst candidate variants.
We also used the FGWAS software and its associated annotation file
(containing 450 genomic annotations of various types), applied to our full set of
GWMA results, to investigate the extent to which genetic variants associated with
PBC were enriched within specific annotation categories12. Testing each annotation
individually, we found 75 annotations that showed enrichment (Po0.01) of
GWMA association signals; as many of these annotations are correlated with one
another we used a stepwise selection approach followed by cross-validation to
mitigate overfitting (similar to the procedure performed by Pickrell12) on these 75
annotations to identify a final best-fitting model that included 6 annotations.
Annotation information used by FGWAS was derived from a variety of sources
including Maurano et al.29, Thurman et al.30 and Hffman et al.31 (see Appendix of
Pickrell12 for details).
Pathway analysis. Using summary results from the GWMA (effect size, standard
error and allele frequency) along with SNP linkage disequilibrium estimated from
the Italian GWAS individual-level genotype data, we performed approximate
conditional analysis using the software GCTA13. Only the independently associated
signals with conditional P value and PGWMA botho0.001 were retained for further
consideration. We submitted the rsIDs and PGWMA of these SNPs as well as gene
sets from BioCarta, KEGG, PID and Reactome curated by MSigDB (as of 26 March
2014) to the i-GSEA4GWAS web server14. This programme identified genes within
20 kb of the SNPs and represented each gene by the greatest –log PGWMA of the
SNP(s) mapped to it. Gene sets were then assessed for enrichment with significant
genes while SNP label permutations were conducted to correct for bias from
variations in gene size and gene set size. False discovery rate was used to correct for
multiple testing based on the distributions of enrichment scores generated by
permutation.
Drug-pathway analysis. To identify drugs that affected the pathways associated
with PBC (when the HLA locus was excluded), we first identified the genes
participating in each pathway. We then downloaded drug–gene associations from
the Drug Gene Interaction database15 and scored each drug by the proportion of
each its targets that were in each pathway, which we termed as the drug’s pathway
specificity. As a secondary scoring metric, we evaluated the proportion of each
pathway affected by the drug using the Jaccard index on the respective sets of
pathway genes and targeted genes. To identify promising drug candidates, we
ranked drugs first by our primary specificity metric and then by the secondary
Jaccard index.
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